Buprenorphine and Naloxone
A recent press release for Bunavail says it all: First and Only FDA-Approved (Buccal Formulation) of Buprenorphine and Naloxone to compete in the $1.7 Billion and Growing U.S. Opioid Dependence Market. Heroin and prescription opiate addiction are massive, under-treated and under-reported conditions in the United States. According to 2013 estimates, there are over 669,000 opiate…
Read More